Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Bio N Tech
Bio N Tech
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
Therapeutic: ensifentrine for chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD) comes in various guises, including chronic bronchitis and emphysema; and, although incurable, the symptoms can be managed with...
Merck’s clesrovimab meets all primary endpoints in Phase IIb/III trial for RSV in infants
A teaser of the Phase IIb/III trial released by Merck indicates that clesrovimab can reduce the need to medically attend lower respiratory infections caused by RSV in infants
Bringing biotech to the Baltics: the rise of Lithuania
Lithuania’s biotechnology competencies lie in cell and gene therapies, enzymes and the wider pharmaceutical industry, offering companies a rich pool of talent in a...
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Manufacturing
Eurofarma to manufacture Pfizer-BioNTech doses for Latin America
Annual production is planned to exceed 100 million COVID-19 vaccine doses annually and all of these will exclusively be distributed within Latin America
Manufacturing
Biovac to manufacture Pfizer-BioNTech vaccine for African Union
Pfizer and BioNTech expect the Cape Town facility to be incorporated into the vaccine supply chain by the end of 2021
Manufacturing
Takara Bio signs license and supply agreement with BioNTech
Under the agreement BioNTech is allowed to use RetroNectin for production of its cell & gene therapy products
Manufacturing
Evonik delivers first lipids from German facility to BioNTech
The lipids are used for Pfizer and BioNTech's COVID-19 vaccine, as part of a lipid nanoparticle
Finance
Report details relative uptake of COVID-19 vaccines in EU
$746 m worth of the vaccines have been distributed in the EU with Pfizer taking 67% market share
Packaging
Softbox supports Pfizer in COVID-19 vaccine distribution
When correctly managed, the company says, the ULT Shipper can be used to store vaccines for in excess of 30 days
Manufacturing
AMRI provides excipient manufacturing services for Pfizer-BioNTech
The company has been chosen as part of a network of manufacturers to support the vaccine's continued supply
Subscribe now